BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32120306)

  • 1. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
    Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
    Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
    Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
    Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
    AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
    Gan C; Robertson PL; Lai JKC; Szer J
    Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur.
    Cohen A; Shen W; Dempster DW; Zhou H; Recker RR; Lappe JM; Kepley A; Kamanda-Kosseh M; Bucovsky M; Stein EM; Nickolas TL; Shane E
    Osteoporos Int; 2015 Oct; 26(10):2471-8. PubMed ID: 25986383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
    Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
    Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.
    Elstein D; Haims AH; Zahrieh D; Cohn GM; Zimran A
    Blood Cells Mol Dis; 2014; 53(1-2):56-60. PubMed ID: 24581483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.
    Lai JKC; Robertson PL; Goh C; Szer J
    Blood Cells Mol Dis; 2018 Feb; 68():121-125. PubMed ID: 28187999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
    Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
    Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
    Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
    AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and magnetic resonance spectroscopy assessment.
    Ecklund K; Vajapeyam S; Mulkern RV; Feldman HA; O'Donnell JM; DiVasta AD; Gordon CM
    Pediatr Radiol; 2017 Jul; 47(8):952-962. PubMed ID: 28432403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy.
    Salas-Ramirez M; Tran-Gia J; Kesenheimer C; Weng AM; Kosmala A; Heidemeier A; Köstler H; Lassmann M
    Phys Med Biol; 2018 Jan; 63(2):025029. PubMed ID: 29130901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of IDEAL-IQ in Quantifying Femoral Bone Marrow Involvement in Gaucher Disease.
    Hou B; Cidanwangjiu ; Zhang H; Wang F; Qiu Z; Zhang Y; Jin Z
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):637-642. PubMed ID: 37382507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?
    Baum T; Yap SP; Karampinos DC; Nardo L; Kuo D; Burghardt AJ; Masharani UB; Schwartz AV; Li X; Link TM
    J Magn Reson Imaging; 2012 Jan; 35(1):117-24. PubMed ID: 22190287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease.
    Razek AAKA; Abdalla A; Barakat T; El-Taher H; Ali K
    Clin Imaging; 2018; 51():318-322. PubMed ID: 29958157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
    Mariani G; Perri M; Minichilli F; Ortori S; Linari S; Giona F; Di Rocco M; Cappellini MD; Guidoccio F; Erba PA
    AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.